(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line - 2The Specialty of Compromise: Examples from Reality
- 3Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth
- 4Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- 5Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- Which Film Has the Incomparable Melodic Score?
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- 7 Strange Devices to Make Your Party Stick Out!
- Looking for a great Thanksgiving side dish recipe? These are the crowd-pleasers the Yahoo team swears by.
- How did humans evolve, and will we evolve more?
- Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say
- Triple polar vortex to plunge central and eastern U.S. into Arctic cold through mid-December
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
